Risk factors for hepatitis C virus infection in the Colombian Caribbean coast: A case-control study

Ismael de Jesús Yepes, Beatriz Lince, Clara Caez, Giovanni de Vuono, .

Keywords: Hepatitis C, risk factors, case studies, blood transfusion, Caribbean region, Colombia

Abstract

Introduction: An estimated 6.8-8.9 million people are infected with hepatitis C virus in Latin America, of which less than 1% receives antiviral treatment. Studies so far in Colombia have attempted to determine the prevalence of the disease in some risk groups, thus preventing the identification of other factors potentially involved in the spread of the infection.
Objectives: To identify traditional and non-traditional risk factors for chronic hepatitis C in the Colombian Caribbean coast.
Materials and methods: This was a case-control study (1:3) matched by health care provider and age (± 10 years) conducted at the primary care level of gastroenterology and hepatology outpatient services. All patients with a positive ELISA underwent a confirmatory viral load test. A multivariate logistic regression analysis identified the independent predictors of infection.
Results: Blood transfusion (OR=159.2; 95% CI: 35.4-715; p<0.001) and history of hospitalization before 1994 (OR=4.7; 95% CI: 1.3-17.1; p=0.018) were identified as the only two independent predictors of infection.
Conclusion: It is necessary to check the reproducibility of these results and to conduct cost-effectiveness studies before recommending their use in the design of new screening strategies.

Downloads

Download data is not yet available.
  • Ismael de Jesús Yepes Facultad de Medicina, Universidad de Cartagena, Cartagena, Colombia Pharos Centro de Investigaciones Biomédicas de la Costa, Cartagena, Colombia
  • Beatriz Lince Servicio de Gastroenterología, Clínica del Bosque, Cartagena, Colombia
  • Clara Caez Sección de Hepatología, Clínica Portoazul, Barranquilla, Colombia
  • Giovanni de Vuono Pharos Centro de Investigaciones Biomédicas de la Costa, Cartagena, Colombia

References

Kershenobich D, Razavi HA, Sánchez-Ávila JF, Bessone F, Coelho HS, Dagher L, et al. Trends and projections of hepatitis C virus epidemiology in Latin America. Liver Int. 2011;31(Suppl.2):18-29. http://dx.doi.org/10.1111/j.1478-3231.2011.02538.x

Beltrán M, Raad J, Ayala M, Ching R. Tamizaje de enfermedades infecciosas en bancos de sangre, Colombia, 1995. Biomédica. 1997;17:137-42. http://dx.doi.org/10.7705/biomedica.v17i2.938

Cortés AB, Beltrán M, Olaya B, Hernández M. Riesgo de enfermedades infecciosas transmitidas por transfusión en el Valle del Cauca, Colombia. Colomb Med. 1999;30:13-8.

Schmunis GA, Zicker F, Cruz JR, Cuchi P. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Am J Trop Med Hyg. 2001;65:924-30.

Botero RC, Tagle M. Los nuevos tratamiento de hepatitis C: perspectivas latinoamericanas. Clinical Liver Disease. 2015;5:11-3. http://dx.doi.org/10.1002/cld.466

Arroyave JC, Álvarez C, Correa G, Balcázar NM, Arbeláez MP, Navas MC. Infección por el virus de la hepatitis C en individuos transfundidos antes de 1994 en Antioquia, Colombia. Rev Col Gastroenterol. 2014;29:383-9.

Beltrán M, Navas MC, De la Hoz F, Muñoz M, Jaramillo S, Estrada C, et al. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J Clin Virol. 2005;34(Suppl.2):S33-8. http://dx.doi.org/10.1016/S1386-6532(05)80032-0

Ramírez R, Fernández J, Guevara JG, Valderrama LA, León A, Arango J, et al. Prevalencia de anticuerpos contra el virus de hepatitis C en unidades de diálisis de Cali-Colombia. Rev Col Gastroenterol. 2010;25:14-8.

Sepúlveda-Árias JC, Isaza C, Vélez JP. Hepatitis B and C prevalence among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Pereira, Colombia. J Infect Dev Ctries. 2014;8:1228-30. http://dx.doi.org/10.3855/jidc.4525

Bautista H, Jaimes BZ, Hincapié ML. Ausencia de infección por virus de la hepatitis C en usuarios de drogas ilícitas en la ciudad de Bucaramanga, Colombia. Rev Col Gastroenterol. 2011;26:15-20.

Jaramillo C, Rubio A. Encuesta sobre conocimientos, actitudes y prácticas de riesgo para la infección por VHB y VHC en el personal asistencial del Instituto de los Seguros Sociales. Tribuna Médica. 1996;94:20-5.

Alvarado-Mora MV, Fernández MF, Gómes-Gouvea MS, de Azevedo-Neto RS, Carrilho FJ, Pinho JR. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation? PLoS One. 2011;6:e18888. http://dx.doi.org/10. 1371/journal.pone.0018888

Montañez AR. Prevalencia de la hepatitis C en comunidades indigenas: Ika, Chimila, Wayuu, Kogui, Wiwa de la península de La Guajira de Colombia. (tesis). Bogota: Universidad Pontificia Bolivariana; 1996.

Prieto JE, Sánchez S, Rojas L, Huertas S. Hepatitis C crónica: aspectos clínicos, serológicos y de tratamiento en dos centros de atención en Bogotá, Colombia. Rev Col Gastroenterol. 2014;29:424-32.

Di Filippo D, Cortés-Mancera F, Beltrán M, Arbeláez MP, Jaramillo S, Restrepo JC, et al. Molecular characterization of hepatitis C virus in multi-transfused Colombian patients. Virol J. 2012;9:242. http://dx.doi.org/10.1186/1743-422X-9-242

van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308:2584-93. http://dx.doi.org/10.1001/jama. 2012.144878

Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Muhlberger N, et al. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology. 2012;143:974-85. http://dx.doi.org/10. 1053/j.gastro.2012.05.054

Mazzanti MA. Declaración de Helsinki, principios y valores bioéticos en juego en la investigación médica con seres humanos. Revista Colombiana de Bioética. 2011;6:125-44.

Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis. 1998;4:5-11. http://dx.doi.org/10.3201/eid0401.980102

Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61:1-32.

Brener L, Gray R, Cama EJ, Treloar C. ‘Makes you wanna do treatment’: Benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand. Health Soc Care Community. 2013;21:216-23. http://dx.doi.org/10.1111/hsc. 12009

Evon DM, Simpson K, Kixmiller S, Galanko J, Dougherty K, Golin C, et al. A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment. Am J Gastroenterol. 2011;106:1777-86. http://dx.doi.org/10.1038/ajg.2011.219

How to Cite
1.
Yepes I de J, Lince B, Caez C, de Vuono G. Risk factors for hepatitis C virus infection in the Colombian Caribbean coast: A case-control study. biomedica [Internet]. 2016 Dec. 1 [cited 2024 May 11];36(4):564-71. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/3105

Some similar items:

Published
2016-12-01
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code